AU614660B2 - Physiological probe - Google Patents

Physiological probe Download PDF

Info

Publication number
AU614660B2
AU614660B2 AU40803/89A AU4080389A AU614660B2 AU 614660 B2 AU614660 B2 AU 614660B2 AU 40803/89 A AU40803/89 A AU 40803/89A AU 4080389 A AU4080389 A AU 4080389A AU 614660 B2 AU614660 B2 AU 614660B2
Authority
AU
Australia
Prior art keywords
wavelength
radiation
probe
received
magnitude
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40803/89A
Other versions
AU4080389A (en
Inventor
David William Bishop
Keith William Jeffcoat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polartechnics Ltd
Original Assignee
Polartechnics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polartechnics Ltd filed Critical Polartechnics Ltd
Priority to AU40803/89A priority Critical patent/AU614660B2/en
Publication of AU4080389A publication Critical patent/AU4080389A/en
Application granted granted Critical
Publication of AU614660B2 publication Critical patent/AU614660B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By Optical Means (AREA)

Description

i 4 6 Ref: 66303 FORM 10 COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952 COMPLETE SPECIFICATION
(ORIGINAL)
FOR OFFICE USE: Class Int. Class Application Number: PJ0060 :',".Lodged: o c o Priority: Related Art: a 0$ 26 August 1988 Accepted: Published: Name and Address of Applicant: Polartechnics Ltd 9/19 Rodborough Road Frenchs Forest New South
AUSTRALIA
or Wales 2086 a t i i t i Actual Inventor: Address for Service: Keith William Jeffcoat, David William Bishop Spruson Ferguson, Patent Attorneys, Level 33 St Martins Tower, 31 Market Street, Sydney, New South Wales, 2000, Australia Complete Specification for the invention entitled: Physiological Probe The following statement is a full description of this invention, including the best method of performing it known to me/us REPRINT OF RECCIPT S0097'39 25 ZOO/ 8 5815/2 Signatucr of ec larant(s) K.W. JEFFCOAT SFP3 To: The Commissioner of Patents SFP3 11/81 -1
ABSTRACT
A method of, and apparatus for, identifying human tissue which is suspected of being physiologically changed as a result of commencement of neoplastic activity or pre-activity, is disclosed. The tissue is preferably irradicated with light at wavelengths of 660nm and 940nm. The magnitudes of the reflected, or non-absorbed, light at the two wavelengths is compared, preferably after being normalised by the magnitude of ambient light reflected from the tissue immediately prior to each measurement. The invention finds application in detecting cervical lesions but is also applicable to endoscope inspectable tissues such as the lungs and alimentary canal tissues.
r4 tO 4t 0 I I 4441
V
*444l I 00 4d 0 0 00) 0000 0004 (0 4002 4091 S 4 4 o gr/4,
XA
4/ l T -I aP a anr aai oo 0 000'0 o
A
The present invention relates to a physiological probe for identifying tissue which Is suspected of being physiologically changed as a result of commencement of neoplastic activity or pre-activity.
Although the preferred embodiment of the present invention to be described hereafter has particular application to cervical lesions, the present invention is also applicable to lesions of various tissues which can be inspected by means of an endoscope, for example, which can be inserted into the lungs, into the abdominal canal, or into the rectum.
Thus the present invention is not generally applicable to tissues of interior organs such as the liver or kidneys.
It is believed that by doing a spectral analysis of the tissue an indicator of cancerous or pre-cancerous activity can be found.
When viewed under white light, this cancerous or pre-cancerous activity makes itself apparent by increased redness of the tissue.
However, because there is a wide variety of perceived colour, bought about by the reflection, or non-absorption, of light by tissue, it is not possible to accurately predict the presence or absence of neoplastic activity simply based on the colour of the tissue alone.
Although white light is convenient to use, white light represents 20 only a very small band of wavelengths of electromagnetic radiation in the range of, say, from 200nm to 12,000nm which maybe loosely classed as having properties similar to that of light. This band of wavelengths includes ultraviolet light, visible light and infra red radiation. It is generally desirable to work with a wavelength close to visible light since the further one moves away from this band of wavelengths, the more difficult and complicated the apparatus generally becomes. A major advantage of electromagnetic radiation in this region is that it is not effected by, for example, mucus present on the cervix.
For many years the presence of cervical cancer has been detected using a process known as the Pap Smear. This is a chemical test which relies upon the collection of a sample of material immediately adjacent the opening of the cervix. This test is not as reliable as it might be because of variations introduced by the ability of the operator to accurately take a sample, the need for the sample to be sent away to a laboratory for analysis where the sample is viewed under magnification by an operator who makes a subjective assessment of the tissue.
If a positive result is produced, the patient is ther examined by means of a colposcope which enables a magnified view of the cervix to be a a -3examined by a skilled practitioner who makes a subjective judgement of the tissue observed. Any suspect regions of the cervix can then be burnt away using a laser, for example, and the cervical tissue then re-grows.- Such easy preventative treatment is only possible if the lesion is detected at an early stage. Since Pap Smears are normally conducted on an annual basis, a faulty test during one year can mean that a lesion is not detected until the following year, at the earliest.
It is the object of the present invention to substantially overcome, or ameliorate, the disadvantages inherent in Pap Smear testing by the provision of a physiological probe which enables a substantially instantaneous and objective indication of the presence or absence of neoplastic activity to be provided.
The essential advance inherent in the present invention is the 'fit, measurement of the magnitude of electromagnetic radiation in the near light S 15 region mentioned above reflected from the tissue at two different wavelengths. The ratio of the reflected magnitudes appear to provide a reliable indication of the presence or absence of neoplastic activity.
According to the present invention there is disclosed a physiological probe for identifying cervical tissue which is suspected of being physiologically changed as a result of commencement of neoplastic activity or pre-activity of a cervical lesion, said probe having one end shaped to face said cervical tissue and comprising at least two paths for electromagnetic radiation in the range of from 200nm to 12,000nm, at least one of said paths leading to said one end and arranged to convey said electromagnetic radiation in a first direction towards said one end, and at least one of said paths leading from said one end and arranged to convey said electromagnetic radiation in a second direction away from said one end; a first electromagnetic generator means connected to said at least one first direction path to transmit said electronic radiation at a first wavelength within said range along one of said first direction paths and a second electromagnetic generator means to transmit said electromagnetic radiation at a second wavelength within said range along one of said first direction paths, said second wavelength being different from said first wavelength; receiver means connected to said at least one second direction to receive said radiation at said first and second wavelengths reflected by said tissue, and comparator means to generate the ratio of the magnitudes Agr/403y -4of said received radiation and compare same with known ratios to thereby identify tissue condition.
In one form two paths only are provided. A single receiver and two generators are provided with the generators transmitting alternatively. If preferred two receivers can be provided and switched to operate from the single return path.
In another form three paths are provided. A single receiver is connected to the return path and each generator is connected to a corresponding sending path. In a further form four paths are provided with two receivers each connected to a corresponding return path.
Embodiments of the present invention will now be described with reference to the drawings in which: U ".Fig. 1 is a schematic representation of the probe of the preferred o, embodiment approaching contact with the tissue of a cervix, S 15 Fig. 2 is a graph of the timing relationships of the apparatus of Fig. 1, ~Fig. 3 illustrates in schematic form the circuit arrangement required .to realize the apparatus of Fig. 1, Fig. 4 is a view similar to Fig. 1 but illustrating an alternative arrangement of paths, Fig. 5 is a view of a probe of a further embodiment illustrating a still further arrangement of optical paths, and Figs. 6 and 7 are schematic cross-sectional views of a cervix illustrating respectively the correct and incorrect probe attitudes.
Turning now to Fig. 1, the probe 1 of the preferred embodiment comprises a generally cylindrical housing 2 for three optical fibres Optical fibre 3 is a sending path and connects to the probe 1 a red light generator 6 which can operate in the range of from 650nm to 850nm but which preferably operates at approximately 660nm. Similarly, optical fibre 4 is also a sending path and connects to the probe 1 an infra-red generator 7 operating in the range of from 850nm to 1000nm but preferably operates at a near infra-red wavelength of 940nm. However, optical fibre 5 is a return path which connects the probe 1 to a receiver 8. Alternatively the generator and detector devices can be on the probe tip for direct coupling to the tissue without the intervention of optical fibres.
Fig. 3 illustrates in schematic form a practical realization of the apparatus of Fig. 1. The generators 6 and 7 are realized by LED optical transmitters whilst the receiver 8 is realized by a photo diode receiver.
f /403y
FI
4 4 44 4 tO 4444 4,4, 4444 t 44 A synchronizing circuit 19 controls the operation of the generators 6, 7 and receiver 8. The output of the receiver 8 is passed to a logic circuit for processing which in turn triggers an alarm 21 as required.
Nith the tips of the fibres 3 and 5, and hence the tip of the probe 5 1, in contact with the tissue of the cervix 9, red light is first passed from generator 6 down optical fibre 3 and a portion thereof is reflected along return path 5 and received at the receiver 8.
The timing diagrams used in the circuit of Fig. 3 are illustrated in Fig. 2. The upper trace represents the pulses of red light emitted by generator 6 in accordance with the signals provided to it by the synchronizing circuit 19. Similarly, the second trace from the top represents the pulses of infra red light emitted by generator 7.
The third trace from the top illustrated in Fig. 2 is applied to the receiver 8 and enables the receiver 8 to sample the intensity of light 15 created by the generator 6 and thus constitutes a red signal magnitude.
Similarly, the next trace is also applied to the receiver 8 and samples the magnitude of infra red light generated or emitted by generator 7. Thus an infra red signal magnitude is sampled by the receiver 8. 3oth signals are stored in the logic circuit 20 The penultimate trace when applied to the receiver 8 permits the ambient light reflected from the tissue of the cervix 9 to be passed along optical fibre 5 to be sampled. Thus the magnitude of the reflected ambient light (termed red base radiation), before the red reflected light is sampled, is also stored in the logic circuit 20. Finally, the last trace in Fig. 2 illustrates the waveform applied to the receiver 8 in order to sample the ambient radiation reflected from the tissue of the cervix (termed infra red base radiation), before the infra red light is sampled.
The logic circuit 20 generates a ratio formed by the difference between the sampled reflected red radiation and the sampled base red radiation, divided by the sampled reflected infra red radiation less the magnitude of the sampled base infra red radiation.
If this ratio is approximately 1, this indicates that the tissue is normal. If the ratio is approximately 10 to 20% higher this indicates that the tissue is undergoing change which suggests neoplasia or pre-neoplasia metaplastic and if the ratio is approximately 20 to 50% lower then this indicates necrotic tissue suggestive of an advanced neoplasm.
In this connection, it will be appreciated that the signals from the Sreceiver 8 are preferably filtered with a filter having a time constant of g /403y -6the order of 12 ms so that any oscillations occurring within this time are averaged. As the pulse repetition rate of the signals from the synchronizing circuit 19 is approximately 500Hz, this enables any noise due to the movement of the probe over tissue, or short term perturbations of the signals, and the like to be filtered out.
t It has been found that two wavelengths are required because the reflection, or absorption of a given wave length of "light" changes with time, largely due to the patient's pulse, and also with the location of the probe on the cervix. However, the ratio of the normalized magnitudes of the reflected "light" at two wavelengths appears to be substantially constant for a given type of tissue.
In this connection, it has been found that neoplastic change in tissue shows as a change in dielectric, which in turn gives a change in I reflectivity. Early neoplastic change of tissue has a higher reflectivity or red light than normal cells.
S oConversely, the cells of necrotic tissue at the centre of advanced neoplastic tissur have a negligible or poor blood supply and therefore have a very low red reflectivity.
It is desirable that the logic circuit 20 be arranged so that if the ratio exceeds 10 to 20% above normal a first audible alarm is sounde'd, if the ratio falls 20 to 50% below normal a second audible alarm is sounded and that if both conditions are experienced within a predetermined period of time, indicative of the probe moving from one extreme type of cancerous tissue to the other, then a third audible alarm is sounded. Such audible alarms are useful because the probe can be operated alongside a colposcope and thus the operator of the colposcope is watching the cervix thereof and his eyes are fully occupied and unable to appreciate the flashing, for example, of an alarm light or other means of visual information.
Turning now to Fig. 4, a second embodiment of the physiological probe of the present invention is schematically illustrated. In this probe 10 a single sending path 13 to which both generators 16 and 17 are connected is provided. The return path 14 to which receiver 18 is connected is substantially the same.
It will be apparent that the timing arrangements for the probe 10 of Fig. 4 are substantially similar to that of the probe 1 of Figs. 1 and 3 except that the red and infra red radiation passes sequentially along the single setding optical path 13.
An alternative arrangement with dual receivers which are responsive i
J
-7only to a given one of the two wavelengths will be apparent to those skilled in the art. Such dual receivers can both be connected to a single return path, or alternatively be connected to individual return paths.
Fig. 5 illustrates a further embodiment of the probe 100 which includes a bundle of optical fibres and thereby permits data as to the spacial location of the area of tissue types of interest, to be determined, for example with reference to the centre of the cervix.
Fig. 6 illustrates two correct positions for abutting the probe 1 against the cervix 9. In each instance, it is essential to avoid spurious readings for the probe 1 to be substantially normal to the surface of the cervix.
By way of contrast, Fig. 7 illustrates three erroneous portions of te the probe 1 which may give rise to misleading or spurious indications.
These -rroneous positions essentially are that the probe 1 is not normal to the surface of the cervix and/or that the probe 1 is not actually touching the surface of the cervix.
The foregoing describes only some embodiments of the present ri nvention and modifications, obvious to those skilled in the art, can be made thereto without departing from the scope of the present invention.

Claims (12)

1. A physiological probe for identifying cervical tissue which is suspected of being physiologically changed as a result of commencement of neoplastic activity or pre-activity of a cervical lesion, said probe having one end shaped to face said cervical tissue and comprising at least two paths for electromagnetic radiation in the range of from 200nm to 12,000nm, at least one of said paths leading to said one end and arranged to convey said electromagnetic radiation in a first direction towards said one end, and at least one of said paths leading from said one end and arranged to convey said electromagnetic radiation in a second direction away from said one end; a first electromagnetic generator means connected to said at least one first direction path to transmit said electronic radiation at a first wavelength within said range along one of said first direction paths and a second electromagnetic generator means connected to said at least one first direction path to transmit said electromagnetic radiation at a second wavelength within said range along one of said first direction paths, said second wavelength being different from said first wavelength; receiver means connected to said at least one second direction 20 to receive said radiation at said first and second wavelengths reflected by said tissue, and comparator means to generate the ratio of the magnitudes of said received radiation and compare same with known ratios to thereby identify tissue condition.
2. A probe as claimed in claim 1 wherein said receiver means receives ambient light reflected from said cervical tissue and said comparator means generates a ratio formed by the difference between the magnitude of the received ambient light and the magnitude of the received first wavelength radiation, divided by the difference between the magnitude of the received ambient light and the magnitude of the received second wavelength radiation.
3. A probe as claimed in claim 2 wherein said first and second electromagnetic generator means and receiver means are controlled by a timing means to respectively generate timed pulses of said first and second wavelengths and activate said receiver to determine both the magnitude of the received pulses of said first and second wavelengths and the magnitude of said received ambient light just prior to receipt of said received pulses. 19
4. A probe as claimed in claim 3 wherein at least two of said first g 03y z .r T- C~ direction paths for electromagnetic radiation are provided, said first generator means being connected to one of said first direction path! and said second generator means being connected to the other of said first direction paths, said generators being connected to the end of said paths remote from said one end of said probe.
A probe as claimed in claim 3 wherein said first and second generator means are both connected to the same first direction path at the end thereof remote from said one end of said probe, and said timing means being arranged to generate said first and second wavelength pulses in sequence.
6, A probe as claimed in claim 1 wherein said paths for electromagnetic radiation comprise optical fibres, said first wavelength is in the range of from 650nm to 850nm, said second wavelength is in the range ,foot of from 850nm to lO00nm, and an alarm is connected to the output comparator 0 15 means, said alarm being activitable if said ratio diverges from l o approximately unity. OOOo
7. A method of identifying cervical tissue which is suspected of a* being physiologically changed as a result of commencement of neoplastic activity o pre-activity, said method comprising the steps of irradiating said cervicai tissue with electromagnetic radiation at a first wavelength, irradiating said cervical tissue with electromagnetic radiation at a second wavelength, said first and second wavelengths being different and within the range of from 200nm to 12,000nm, receiving the radiation at said first and second wavelengths reflected by said cervical tissue, generating the ratio of the magnitudes of said received radiation, and identifying the condition of said cervical tissue by comparing said generated ratios with know ratios.
8. A method as claimed in claim 7 including the step of receiving ambient light reflected by said cervical tissue, and measuring the ratio formed by t.e difference between the magnitude of the received ambient light and the magnitude of the received first wavelength radiation, divided by the difference between the magnitude of the received ambient light and the magnitude of tne received second wavelength radiation.
9. A method as claimed in claim 8 wherein each said difference is formed by the magnitude of the received ambient light measured just before the measurement of the received first or second wavelength radiation. A method as claimed in claim 9 wherein said cervical tissue is 1 A irradiated with timed pulses of said first and second wavelength radiation.
V gr/403y I 1 0-
11. A method as claimed in claim 10 wherein said first wavelength is in the range of from 650nm to 850nm and said second wavelength is in the range of from 850nm to 1000nm.
12. A probe substantially as described with reference to Figs. 1 to 3 or Fig. 4 or Fig. 5 of the drawings. i13. A method of identifying tissue which is suspected of being j physiologically changed as a result of commencement of neoplastic activity or pre-activity, said method being substantially as described with reference to the drawings. DATED this TWENTY NINTH day of MAY 1991 Polartechnics Ltd S l Patent Attorneys for the Applicant *SPRUSON FERGUSON til I S'
AU40803/89A 1988-08-26 1989-08-25 Physiological probe Ceased AU614660B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40803/89A AU614660B2 (en) 1988-08-26 1989-08-25 Physiological probe

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ006088 1988-08-26
AUPJ0060 1988-08-26
AU40803/89A AU614660B2 (en) 1988-08-26 1989-08-25 Physiological probe

Publications (2)

Publication Number Publication Date
AU4080389A AU4080389A (en) 1990-03-01
AU614660B2 true AU614660B2 (en) 1991-09-05

Family

ID=25625321

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40803/89A Ceased AU614660B2 (en) 1988-08-26 1989-08-25 Physiological probe

Country Status (1)

Country Link
AU (1) AU614660B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407290A (en) * 1981-04-01 1983-10-04 Biox Technology, Inc. Blood constituent measuring device and method
EP0099756A2 (en) * 1982-07-19 1984-02-01 STOLLER, Milton Diaphanoscopy apparatus
GB2162939A (en) * 1984-08-07 1986-02-12 Sclavo Spa A multiple wavelength light photometer for non-invasive monitoring

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407290A (en) * 1981-04-01 1983-10-04 Biox Technology, Inc. Blood constituent measuring device and method
US4407290B1 (en) * 1981-04-01 1986-10-14
EP0099756A2 (en) * 1982-07-19 1984-02-01 STOLLER, Milton Diaphanoscopy apparatus
GB2162939A (en) * 1984-08-07 1986-02-12 Sclavo Spa A multiple wavelength light photometer for non-invasive monitoring

Also Published As

Publication number Publication date
AU4080389A (en) 1990-03-01

Similar Documents

Publication Publication Date Title
US5036853A (en) Physiological probe
CN100515321C (en) System for detecting dental caries
CA2134423C (en) Method and apparatus for tissue type recognition
US4213462A (en) Optical assembly for detecting an abnormality of an organ or tissue and method
EP1328190B1 (en) Temperature measuring balloon
US6519485B2 (en) Minimally invasive system for assessment of organ function
US4029085A (en) Method for determining bilirubin concentration from skin reflectance
CN100464690C (en) System and method for detection of dental tartar
JP4474050B2 (en) Multi-mode optical tissue diagnosis system
US8024027B2 (en) Infrared endoscopic balloon probes
JP5872750B2 (en) Electronic digestive tract screening
CN100506150C (en) Optical detection device and working method for tissue of living body
US9289172B2 (en) Optoelectronic device for the detection of uterine cervical cancer, comprising a self-positioning attachment
US20090204009A1 (en) Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue
JPH11507568A (en) Sensor for optical measurement of blood oxygen saturation, its measurement method, and its measurement device
JP2001509589A (en) Method and apparatus for laser-induced fluorescence decay spectroscopy
CN201042433Y (en) Living body tissue optical detector
RU2138192C1 (en) Method of identification of tissue type and apparatus for method embodiment
EP1296593A2 (en) Ephitelial diagnostic aid
AU614660B2 (en) Physiological probe
CN102585814A (en) Method and device for identifying type of tissue
WO1999005961A1 (en) Analyzing system with disposable calibration device
JPH0473046A (en) Eye inspector
JPH07250837A (en) Tissue type recognition and device for that
WO2000013578A1 (en) Infrared endoscopic balloon probes